Comparable-price valuation for physician samples applies where goods match market sales, while bona fide confusion bars extended limitation and penalties.

Physician samples identical in substance to market-sold goods were required to be valued on the comparable-price basis under Rule 4 of the Central Excise Valuation Rules, 2000, rather than on cost construction merely because they were distributed free. The demand on merits was therefore sustained for the normal period. However, conflicting departmental circulars had created bona fide uncertainty, and the assessee's adoption of cost construction in that context negatived mala fide intent, so the extended period of limitation was unavailable and penalties were set aside. Duty for the normal period with interest remained payable, but the extended-period demand and penal consequences were annulled.

---

---

Issues: (i) Whether physician samples were required to be valued under the comparable-price method under Rule 4 of the Central Excise Valuation Rules, 2000 instead of cost construction basis; (ii) whether the extended period of limitation and penalties were sustainable.

Issue (i): Whether physician samples were required to be valued under the comparable-price method under Rule 4 of the Central Excise Valuation Rules, 2000 instead of cost construction basis.

Analysis: The samples and the goods sold in the market were found to be the same in substance, with only a difference in packing or quantity. In that situation, valuation could not be based on cost construction merely because the samples were distributed free. The settled position, reinforced by Board circulars and judicial precedent, was that such samples had to be valued with reference to the price of similar goods sold in the market.

Conclusion: The valuation under Rule 4 was upheld and the demand on merits was sustained.

Issue (ii): Whether the extended period of limitation and penalties were sustainable.

Analysis: The record showed conflicting Board circulars on the valuation method, and the assessee had followed cost construction basis in that atmosphere of uncertainty. That supported a bona fide mistaken practice and negatived mala fide intent. In those circumstances, invocation of the extended period was not justified and the penal provisions could not be applied.

Conclusion: The extended period of limitation was not available and the penalties were set aside.

Final Conclusion: The duty demand for the normal period with interest was sustained, while the demand for the extended period and the penalties were annulled.

Ratio Decidendi: Physician samples identical in substance to market-sold goods are to be valued on the comparable price basis, and where conflicting departmental guidance created bona fide confusion, extended limitation and penalties are not justified.

---